San Diego, CA, United States of America

Rajesh K Agarwal

USPTO Granted Patents = 9 


Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Lakewood, CO (US) (2003)
  • Yorktown Heights, NY (US) (2012 - 2014)
  • San Diego, CA (US) (2008 - 2015)

Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Rajesh K Agarwal: Innovator in Pharmaceutical Chemistry

Introduction

Rajesh K Agarwal is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Rajesh has developed crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. This invention includes compositions containing these crystalline forms and their various uses. Additionally, he has patented crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride, further expanding the potential applications of this compound.

Career Highlights

Rajesh has worked with notable companies in the pharmaceutical industry, including Novartis AG and Emisphere Technologies, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Rajesh has collaborated with esteemed colleagues such as Kiran Chaudhary and Michael M Goldberg. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Rajesh K Agarwal is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…